Vaxart, Inc. (VXRT)
0.5016
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Vaxart Debt to Equity Ratio : 0.1522 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1522 |
| March 31, 2026 | 0.1296 |
| December 31, 2025 | 0.1486 |
| September 30, 2025 | 0.7086 |
| June 30, 2025 | 0.5785 |
| March 31, 2025 | 0.4507 |
| December 31, 2024 | 0.3951 |
| September 30, 2024 | 0.3372 |
| June 30, 2024 | 0.2891 |
| March 31, 2024 | 0.4258 |
| December 31, 2023 | 0.4587 |
| September 30, 2023 | 0.3696 |
| June 30, 2023 | 0.315 |
| March 31, 2023 | 0.3052 |
| December 31, 2022 | 0.2479 |
| September 30, 2022 | 0.2823 |
| June 30, 2022 | 0.1727 |
| March 31, 2022 | 0.1485 |
| December 31, 2021 | 0.1308 |
| September 30, 2021 | 0.1361 |
| June 30, 2021 | 0.1055 |
| March 31, 2021 | 0.1231 |
| December 31, 2020 | 0.1794 |
| September 30, 2020 | 0.1324 |
| June 30, 2020 | 0.4074 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.517 |
| December 31, 2019 | 1.440 |
| September 30, 2019 | 1.117 |
| June 30, 2019 | 1.218 |
| March 31, 2019 | 1.681 |
| December 31, 2018 | 1.90 |
| September 30, 2018 | 1.355 |
| June 30, 2018 | 0.9655 |
| March 31, 2018 | 0.6927 |
| June 30, 2017 | 0.016 |
| March 31, 2017 | 0.7231 |
| December 31, 2016 | 0.6893 |
| September 30, 2016 | 0.0191 |
| June 30, 2016 | 0.0152 |
| March 31, 2016 | 0.0152 |
| December 31, 2015 | 0.0157 |
| September 30, 2015 | 0.0142 |
| June 30, 2015 | 0.0144 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 165.18M |
| Total Liabilities (Quarterly) | 82.81M |
| Shareholders Equity (Quarterly) | 82.37M |
| Current Ratio | 1.596 |
| Net Debt Paydown Yield | 1.09% |